Abstract:RATIONALE: Genome-wide association studies (GWAS) have identified common variants of lung cancer. However, the contribution of rare exome-wide variants, especially protein-coding variants, to cancers remains largely unexplored.OBJECTIVES: To evaluate the role of human exomes in genetic predisposition to lung cancer.MEASUREMENTS AND METHODS: We performed exome-wide association studies (ExWAS) to detect the association of exomes with lung cancer in 30,312 patients and 652,902 controls. A Scalable and Accurate Implementation of GEneralized (SAIGE) mixed model was used to detect the association signals for loss of function (LoF), missense and synonymous variants, and gene-level sets. Furthermore, we performed association and Bayesian co-localization analyses to evaluate their relationships with intermediate exposures.MAIN RESULTS: We systematically analyzed 216,739 single nucleotide variants (SNVs) in the human exome. The LoF variants exhibited the most notable effects on lung cancer risk. We identified four novel variants, including two missense variants (rs202197044TET3 [Pmeta = 3.60×10-8] and rs202187871POT1 [Pmeta = 2.21×10-8]) and two synonymous variants (rs7447927TMEM173 [Pmeta = 1.32×10-9] and rs140624366ATRN [Pmeta = 2.97×10-9]). rs202197044TET3 was significantly associated with emphysema (OR = 3.55, Pfdr = 0.015), whereas rs7447927POT1 was strongly associated with telomere length (beta = 1.08, Pfdr = 3.76×10-53). Functional evidence of expression quantitative trait loci (eQTL), splicing QTL (sQTL), and isoform expression was found for the four novel genes. Gene-level association tests identified several novel genes, including POT1, RTEL1, BSG, and ZNF232.CONCLUSIONS: Our findings provide insights into the genetic architecture of human exomes and their role in lung cancer predisposition.

A Large-Scale Exome-Wide Association Study Identifies Novel Germline Mutations in Lung Cancer